Ethyl dirazepate
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
ethyl 7-chloro-5-(2-chlorophenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepine-3-carboxylate | |
| Identifiers | |
| CAS Number |
23980-14-5 |
| PubChem | CID 208941 |
| ChemSpider | 181035 |
| UNII |
74FAA305EW |
| ChEMBL |
CHEMBL2106231 |
| Chemical data | |
| Formula | C18H14Cl2N2O3 |
| Molar mass | 377.221 |
| |
| |
| | |
Ethyl dirazepate[1] is a drug which is a benzodiazepine derivative which was developed by Sanofi Winthrop. It has anxiolytic and hypnotic and possibly other characteristic benzodiazepine properties.[2][3][4]
See also
References
- ↑ ZA Patent 6804601
- ↑ "ethyl dirazepate". psychotropics.dk. 2003. Retrieved 7 December 2009.
- ↑ "Drugs of the Future". Thomson Reuters 6 (11). November 1981.
- ↑ "LIST OF INTERNATIONAL NON-PROPRIETARY NAMES (INNS), PROVIDED FOR PHARMACEUTICAL SUBSTANCES BY THE WORLD HEALTH ORGANIZATION, WHICH ARE FREE OF DUTY" (PDF). Official Journal of the European Communities (eur-lex.europa.eu). 23 October 2001. Retrieved 7 December 2009.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Wednesday, April 20, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
